137
Views
8
CrossRef citations to date
0
Altmetric
Letters to the Editor

Sequential single-agent obatoclax mesylate (GX15–070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma

, , , , , & show all
Pages 2932-2934 | Received 18 Sep 2013, Accepted 27 Feb 2014, Published online: 22 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ruth Alonso-Alonso, Marta Rodriguez, Daniel Morillo, Raul Cordoba & Miguel A Piris. (2020) An analysis of genetic targets for guiding clinical management of follicular lymphoma. Expert Review of Hematology 13:12, pages 1361-1372.
Read now
Jung-Chen Su, Chuan-Hsun Chang, Szu-Hsien Wu & Chung-Wai Shiau. (2018) Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1. Journal of Enzyme Inhibition and Medicinal Chemistry 33:1, pages 1248-1255.
Read now
Jennifer R. Brown, Bethany Tesar, Lijian Yu, Lillian Werner, Naoko Takebe, Evgeny Mikler, Hazel M. Reynolds, Christina Thompson, David C. Fisher, Donna Neuberg & A. S. Freedman. (2015) Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia. Leukemia & Lymphoma 56:12, pages 3336-3342.
Read now
Elizabeth A. Brem & Matthew S. Davids. (2014) Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?. Leukemia & Lymphoma 55:12, pages 2675-2677.
Read now

Articles from other publishers (4)

Magdalena Klanova & Pavel Klener. (2020) BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas. Cancers 12:4, pages 938.
Crossref
Natalie Yan Li Ngoi, Clarice Choong, Joanne Lee, Gregory Bellot, Andrea LA Wong, Boon Cher Goh & Shazib Pervaiz. (2020) Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer. Cancers 12:3, pages 574.
Crossref
Rebecca Valentin, Stephanie Grabow & Matthew S. Davids. (2018) The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood 132:12, pages 1248-1264.
Crossref
Rui‐Fang Sun, Qian‐Qian Yu & Ken H. Young. (2018) Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies. Chronic Diseases and Translational Medicine 4:1, pages 29-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.